Evidence map›Paper›PMID 23968620›Full record

ArticleAnnals of the rheumatic diseases2014

Comparison of the American-European Consensus Group Sjogren's syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort.

Astrid Rasmussen, John A Ice, He Li, Kiely Grundahl, Jennifer A Kelly, Lida Radfar, Donald U Stone, Kimberly S Hefner, Juan-Manuel Anaya, Michael Rohrer and 15 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Annals of the rheumatic diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed, 1 pooled it
13.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 1 synthesis or guideline pooled it, 185 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Gut Dysbiosis and Fecal Microbiota Transplantation in Autoimmune Diseases.International journal of molecular sciences · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Sjögren's syndrome: a systemic autoimmune disease.Clinical and experimental medicine · 2022
    Review
  19. Article
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 9 institutions in 3 countries.

Astrid RasmussenArthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, , Oklahoma City, Oklahoma, USA.
John A Ice
He Li
Kiely Grundahl
Jennifer A Kelly
Lida Radfar
Donald U Stone
Kimberly S Hefner
Juan-Manuel Anaya
Michael Rohrer
Rajaram Gopalakrishnan
Glen D Houston
David M Lewis
James Chodosh
John B Harley
Pamela Hughes
Jacen S Maier-Moore
Courtney G Montgomery
Nelson L Rhodus
A Darise Farris
Barbara M Segal
Roland Jonsson
Christopher J Lessard
R Hal Scofield
Kathy L Moser Sivils
Oklahoma Medical Research Foundation · USUniversity of Minnesota · USUniversity of Oklahoma Health Sciences Center · USHarvard University · USHaukeland University Hospital · NOHennepin County Medical Center · USUniversidad del Rosario · COUniversity of Oklahoma · USVeterans Health Administration · US

Funding

Pathogenic B Cells in Sjogren's SyndromeP50AR060804 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI SIVILS, KATHY L. · 2011 to 2015
$7.9M
Pre-Clinical Studies to Identify SLE Therapeutic TargetsU19AI082714 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GAFFNEY, PATRICK M · 2009 to 2018
$6.2M
Genetic Linkage in LupusR37AI024717 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI HARLEY, JOHN BARKER · 2005 to 2014
$4.2M
Gene Expression Profiling in Sjogren's SyndromeR01AR050782 · NIAMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI SIVILS, KATHY L. · 2003 to 2006
$1.3M
Susceptibility Genes in Primary Sjogren's SydromeR01DE018209 · NIDCR · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI HARLEY, JOHN BARKER, SIVILS, KATHY L. · 2009 to 2010
$489k
BLRD VA I01 BX001451NIAID NIH HHS 5R37AI024717-22S1NIAID NIH HHS 5U19 AI 082714NIAID NIH HHS R37 AI024717NIAID NIH HHS U19 AI082714NIAMS NIH HHS 5R01 AR50782NIAMS NIH HHS P50 AR060804NIAMS NIH HHS P50 AR0608040NIAMS NIH HHS R01 AR050782NIDCR NIH HHS 5R01 DE018209NIDCR NIH HHS R01 DE018209
6 · The paper itself

Abstract

objectiveTo compare the performance of the American-European Consensus Group (AECG) and the newly proposed American College of Rheumatology (ACR) classification criteria for Sjögren's Syndrome (SS) in a well-characterised sicca cohort, given ongoing efforts to resolve discrepancies and weaknesses in the systems.

methodsIn a multidisciplinary clinic for the evaluation of sicca, we assessed features of salivary and lacrimal gland dysfunction and autoimmunity as defined by tests of both AECG and ACR criteria in 646 participants. Global gene expression profiles were compared in a subset of 180 participants.

resultsApplication of the AECG and ACR criteria resulted in classification of 279 and 268 participants with SS, respectively. Both criteria were met by 244 participants (81%). In 26 of the 35 AECG+/ACR participants, the minor salivary gland biopsy focal score was ≥1 (74%), while nine had positive anti-Ro/La (26%). There were 24 AECG-/ACR+ who met ACR criteria mainly due to differences in the scoring of corneal staining. All patients with SS, regardless of classification, had similar gene expression profiles, which were distinct from the healthy controls.

conclusionsThe two sets of classification criteria yield concordant results in the majority of cases and gene expression profiling suggests that patients meeting either set of criteria are more similar to other SS participants than to healthy controls. Thus, there is no clear evidence for increased value of the new ACR criteria over the old AECG criteria from the clinical or biological perspective. It is our contention, supported by this report, that improvements in diagnostic acumen will require a more fundamental understanding of the pathogenic mechanisms than is at present available.

Indexed as

Sjogren's SyndromeTranscriptomeAdolescentAdultAgedAged, 80 and overCohort StudiesConsensus Statements as TopicEuropeFemaleHumansMaleMiddle AgedUnited StatesYoung AdultClassificationDiagnosisSjögren's syndrome

Identifiers

PMID23968620
PMCPMC3855629
OpenAlexW2127675578

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.